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Introduction
Conventional transbronchial needle aspiration (cTBNA) 
was first performed approximately 30 years ago however 
was never widely adopted until the development of 
endobronchial ultrasound transbronchial needle aspiration 
(EBUS-TBNA) (1,2). Conventional TBNA is performed 
first through procedural planning using a chest CT and 
correlating the images to landmarks within the airway to 
select a puncture site. This is followed by a “blind” needle 
biopsy through the airway wall. During EBUS-TBNA the 
same initial planning is performed followed by real time 
ultrasonographic (US) visualization and biopsy of the target 
lesion. Since its introduction EBUS-TBNA has proven to 
be more dependable and attractive to the bronchoscopist 
than cTBNA (3-5).
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The performance of TBNA with or without EBUS 
are essentially the same, passing a needle through the 
airway wall, however factors above and beyond real time 
US-guidance that may make EBUS-TBNA more effective 
are the 35 degree of angle at the exit of the needle from 
the working channel of the bronchoscope and the stiffness 
of the EBUS needle. These factors have eliminated the 
difficulty of obtaining an adequate angle of entry and the 
consequent need for a more flexible needle in cTBNA. 
In order to determine whether a 19-gauge (19G) needle in 
EBUS-TBNA can further improve the diagnostic yield and 
simplify the methodology of EBUS-TBNA we developed 
a hybrid method. Here we report our initial experience in 
assessing the feasibility of performing EBUS-TBNA using a 
conventional 19G TBNA needle. 
Materials and methods
Patients with diagnosed or suspected lung cancer with or 
without mediastinal or hilar lymphadenopathy (LAD) were 
sampled for diagnostic and/or staging purposes. Patients with 
suspected benign processes were sampled only for diagnosis. 
An EBUS bronchoscope with a 2.2 mm working channel 
was employed. The 19G needles used in performing TBNA 
were the WANG MW319 (Conmed, Utica, NY, USA) 
or an Excelon 19G (Boston Scientific, Marlborough, 
MA, USA). Standard staging technique was employed 
in patients with suspected or known malignancy (6). 
In patients with suspected benign disease the most 
prominent lesion was sampled initially.
 
Hybrid method
Instead of using a standard EBUS-TBNA needle that is 
fixed to the bronchoscope via a locking mechanism we 
utilized a conventional 19G TBNA needle through the 
working channel of the EBUS bronchoscope. The needle 
was fixed in place using a device that locked it in place onto 
the bronchoscope (Figure 1) lessening the natural tendency 
to be pushed back into the scope when resistance is met 
during initial puncture. 
MW319
After insertion of the MW319 needle into the working 
channel of the bronchoscope, the first biopsy was taken 
without retracting the inner 21G needle. Biopsy was 
performed by moving the 21G needle back and forth within 
the lesion 3–5 times under suction. The second aspiration 
biopsy was taken with the inner 21G needle retracted into 
the 19G needle, the exposed 19G needle was then used to 
obtain a “core” specimen for surgical pathology. 
Excelon 
The excelon needle was inserted into the working channel of 
the EBUS bronchoscope then passed through the airway wall 
under ultrasound guidance. Once seen on US, the needle was 
passed back and forth within the lesion 3–5 times. 
Three full needle passes were performed at each target 
lesion. The specimens were then processed for rapid 
on-site cytopathology as well as full histo- and cytopathologic 
evaluation based on the practices of the institution at which 
the procedure was performed. 
Results
Patient 1—left upper lobe lesion with a high suspicion of 
primary lung carcinoma. TBNA with the MW319 needle 
was used to obtain cytology and histology specimens 
at lymph node (LN) stations 4R, 7, 4L and 11L. The 
specimens were diagnostic for adenosquamous lung cancer 
at LN stations 7, 4L and 11L. The histology specimen 
obtained by the 19G needle contributed to the diagnosis of 
Figure 1 Device used to fix and stabilize a conventional TBNA 
needle to the EBUS scope. EBUS-TBNA, endobronchial 
ultrasound transbronchial needle aspiration.
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mixed cell type.
Patient 2—right lower lobe mass of 8 cm in size with a 
normal mediastinum by CT and PET scan. Transbronchial 
biopsy with of the RLL mass was diagnostic of squamous 
cell lung carcinoma. EBUS-TBNA performed for staging 
with MW319 needle for cytology and histology specimen 
at station 4L, 7, and 11R. All specimens were negative for 
malignancy with histological cores revealing anthracotic 
lymphoid tissue. The patient was referred for surgical 
resection. 
Patient 3—bilateral pulmonary nodules with a normal 
mediastinum. EBUS-TBNA of 4L using the MW319 
needle showed adequate lymphoid material but was negative 
for malignancy on the cytology slides. 
Patient 4—right upper lobe nodule with station 4R 
LAD noted on chest CT. EBUS-TBNA was performed 
with the MW319 needle for cytology and histology. All 
specimens obtained were positive for small cell carcinoma, 
core specimens showed small cell carcinoma with extensive 
necrosis. 
Patient 5—LAD suspicious for sarcoidosis. EBUS-
TBNA was performed using the MW319 needle for 
cytology and histology at LN stations 11R, 11L and 7. All 
specimens were diagnostic for non-caseating granuloma 
compatible with sarcoidosis.
Patient 6—history of adenocarcinoma previously treated 
with stereotactic body radiotherapy, now with a chest CT 
suggestive of metastatic recurrence. EBUS-TBNA of the 
subcarinal LN was performed using the 19G Excelon needle 
for cytology and histology. The specimen was positive for 
adenocarcinoma, was sent for molecular analysis and was 
found to be adequate for further testing. 
Patient 7—left lower lobe mass with hilar and mediastinal 
LAD. EBUS-TBNA of the 4R LAD using the 19G Excelon 
needle for cytology and histology. Both cytologic and 
histologic evaluation showed adenocarcinoma. The samples 
were then sent for molecular analysis and were found to be 
adequate.
Patient 8—bilateral pulmonary nodules and adenopathy 
seen on CT. All were FDG-avid on PET/CT. EBUS-
TBNA using the 19G Excelon needle of LN stations 4R, 
4L and 11L showed adequate lymphoid material but no 
malignancy on both cytologic and histologic specimens. 
Bronchoalveolar lavage showed mycobacterium avium 
intracellulare infection. 
Patient 9—patient presenting with progressive weakness, 
found to have moderate sized hilar and mediastinal 
adenopathy. EBUS-TBNA using the 19G Excelon needle of 
LN stations 4R, 7 and 4L showed non-caseating granuloma 
compatible with sarcoidosis on all specimens.
Patient 10—patient presenting with progressive 
weakness, found to have a large left lower lobe mass and 
small adenopathy. EBUS-TBNA using the 19G Excelon 
needle of LN stations 7 and 11L revealed adequate 
lymphoid material. TBNA of the mass showed lymphoma 
on the core histologic specimen.
Conclusions
Conventional TBNA has been employed for approximately 
30 years with some reports indicating use of a histology needle 
as being associated with increased diagnostic yields (7,8). 
Recent development of EBUS-TBNA has validated and 
popularized the technique of TBNA as it provides the 
operator with real-time US visualization of target lesions. 
The ability to visualize and biopsy target lesions external to 
the airways under real time US is perhaps one of the most 
important advances in recent medical history. The value 
of EBUS goes beyond increasing the diagnostic yield of 
TBNA as it plays a vital role in teaching the performance 
of and in understanding the interplay of TBNA and lung 
anatomy in relation to the location of LN (9). 
In this feasibility study we have shown that the 
performance of EBUS-TBNA using a conventional 19G 
histology needle is not only possible but may potentially 
lead to improvements in diagnostic yield due to the ability 
to acquire histological specimens. Previous reports have 
suggested that larger gauge EBUS needles are associated with 
the acquisition of significantly better histology samples (10). 
As of now there is no commercially available dedicated 
19G EBUS-TBNA needle as there is in the 21G and 22G 
sizes. Due to this we utilized conventional TBNA needles 
through the working channel of the EBUS scope. This 
approach may be considered a potential simplification to 
the performance of EBUS as the current available needles 
can at times be cumbersome to operate, especially to those 
practitioners who are previously versed in cTBNA (11,12). 
In addition, use of a conventional 19G is not only effective 
but appears able to assist in the consistent procurement of 
histological specimens. 
One procedure note that should be discussed is the use 
of a fixation device to anchor the scope and needle catheter 
together (Figure 2). The device allows for application of a 
major principal of EBUS-TBNA which is to fix the needle 
to the scope there by alleviating two of the most common 
mistakes performed during TBNA. In standard TBNA 
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the most common mistake is overextension of the needle 
catheter out of the tip of the scope, which leads to a loss of 
scope stiffness and support of the needle catheter making 
puncture through the airway less effective. The second 
most common issue found during TBNA when there is a 
lack of or inadequate fixation of the needle catheter to the 
scope is backward migration of the catheter and needle into 
the working channel of the scope during puncture through 
the airway wall. In our hybrid method the needle catheter 
is fixed to the EBUS scope to anchor the needle and to 
prevent it from been pushed back into the channel of the 
scope when resistance is met during puncture. 
The primary limitation of our study was that it is 
a feasibility trial that was not powered to detect an 
improvement in diagnostic yield or specimen adequacy 
(cytologic or histologic). In addition, the study was not 
randomized in its use of 19G needle types rather it was left 
to facility discretion and available equipment. 
An important note to this study is that EBUS-TBNA 
may not be available at all institutions due to its high 
cost to acquire, maintain and operate. This makes the 
continued teaching of cTBNA all that more important 
and highlights the educational aspect that EBUS bring to 
the bronchoscopist in better understanding the endo- and 
extra-luminal airway anatomy. 
One of the potential strengths of this hybrid method 
is the simplification of EBUS-TBNA which may lead to 
its wider application, improved patient care and superior 
tissue acquisition. This last point is of great importance as 
targetable tumor genes are continuing to be discovered. 
An increasing number of targetable genes makes ‘adequate 
tissue’ a moving target with not only more tissue but tissue 
containing dense, high quality tumor being required. Future 
studies are needed to further delineate this technique and 
should aim to compare the efficacy of the 19G needle with 
the largest (21G) standard EBUS needle and even with one 
another as the MW319 has a unique needle (21G) in needle 
(19G) design developed to decrease specimen contamination 
from retained airway wall debris. Finally, further investigation 
into the quality of specimen obtained from 19G needle for 
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